HUP0102394A2 - Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl)-4-[4-(4pyridyl)benzoyl]piperazine and pharmaceutical compositions containing them and their use - Google Patents
Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl)-4-[4-(4pyridyl)benzoyl]piperazine and pharmaceutical compositions containing them and their useInfo
- Publication number
- HUP0102394A2 HUP0102394A2 HU0102394A HUP0102394A HUP0102394A2 HU P0102394 A2 HUP0102394 A2 HU P0102394A2 HU 0102394 A HU0102394 A HU 0102394A HU P0102394 A HUP0102394 A HU P0102394A HU P0102394 A2 HUP0102394 A2 HU P0102394A2
- Authority
- HU
- Hungary
- Prior art keywords
- chloronaphth
- 4pyridyl
- ylsulphonyl
- piperazine
- benzoyl
- Prior art date
Links
- PSTBXECIKAJFMC-UHFFFAOYSA-N [4-(6-chloronaphthalen-2-yl)sulfonylpiperazin-1-yl]-(4-pyridin-4-ylphenyl)methanone Chemical compound C1=CC2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=NC=C1 PSTBXECIKAJFMC-UHFFFAOYSA-N 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809350.3A GB9809350D0 (en) | 1998-05-02 | 1998-05-02 | Novel salt |
| PCT/GB1999/001316 WO1999057112A1 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0102394A2 true HUP0102394A2 (en) | 2001-12-28 |
| HUP0102394A3 HUP0102394A3 (en) | 2003-01-28 |
Family
ID=10831311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0102394A HUP0102394A3 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1084118A1 (en) |
| JP (1) | JP2002513789A (en) |
| KR (1) | KR20010043216A (en) |
| CN (1) | CN1308629A (en) |
| AU (1) | AU3719699A (en) |
| BR (1) | BR9910176A (en) |
| CA (1) | CA2331041A1 (en) |
| EE (1) | EE200000638A (en) |
| GB (1) | GB9809350D0 (en) |
| HU (1) | HUP0102394A3 (en) |
| IL (1) | IL139405A0 (en) |
| NO (1) | NO20005498D0 (en) |
| PL (1) | PL343705A1 (en) |
| SK (1) | SK16522000A3 (en) |
| WO (1) | WO1999057112A1 (en) |
| ZA (1) | ZA200006036B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69833036T2 (en) * | 1997-09-30 | 2006-06-22 | Daiichi Pharmaceutical Co., Ltd. | sulfonyl |
| TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| WO2003000657A1 (en) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Diamine derivatives |
| DK1569912T3 (en) | 2002-12-03 | 2015-06-29 | Pharmacyclics Inc | 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA56197C2 (en) * | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Heterocyclic derivatives |
| ATE334975T1 (en) * | 1997-05-30 | 2006-08-15 | Takeda Pharmaceutical | SULFONAMIDE DERIVATIVES, THEIR PRODUCTION AND USE |
| DE69833036T2 (en) * | 1997-09-30 | 2006-06-22 | Daiichi Pharmaceutical Co., Ltd. | sulfonyl |
-
1998
- 1998-05-02 GB GBGB9809350.3A patent/GB9809350D0/en not_active Ceased
-
1999
- 1999-04-27 EE EEP200000638A patent/EE200000638A/en unknown
- 1999-04-27 PL PL99343705A patent/PL343705A1/en not_active Application Discontinuation
- 1999-04-27 WO PCT/GB1999/001316 patent/WO1999057112A1/en not_active Application Discontinuation
- 1999-04-27 KR KR1020007012149A patent/KR20010043216A/en not_active Application Discontinuation
- 1999-04-27 BR BR9910176-9A patent/BR9910176A/en not_active IP Right Cessation
- 1999-04-27 IL IL13940599A patent/IL139405A0/en unknown
- 1999-04-27 SK SK1652-2000A patent/SK16522000A3/en unknown
- 1999-04-27 CA CA002331041A patent/CA2331041A1/en not_active Abandoned
- 1999-04-27 EP EP99919395A patent/EP1084118A1/en not_active Withdrawn
- 1999-04-27 CN CN99808217A patent/CN1308629A/en active Pending
- 1999-04-27 JP JP2000547082A patent/JP2002513789A/en active Pending
- 1999-04-27 HU HU0102394A patent/HUP0102394A3/en unknown
- 1999-04-27 AU AU37196/99A patent/AU3719699A/en not_active Abandoned
-
2000
- 2000-10-25 ZA ZA200006036A patent/ZA200006036B/en unknown
- 2000-11-01 NO NO20005498A patent/NO20005498D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK16522000A3 (en) | 2001-05-10 |
| WO1999057112A1 (en) | 1999-11-11 |
| EE200000638A (en) | 2002-04-15 |
| HUP0102394A3 (en) | 2003-01-28 |
| ZA200006036B (en) | 2002-01-25 |
| IL139405A0 (en) | 2001-11-25 |
| NO20005498L (en) | 2000-11-01 |
| JP2002513789A (en) | 2002-05-14 |
| BR9910176A (en) | 2001-01-09 |
| GB9809350D0 (en) | 1998-07-01 |
| NO20005498D0 (en) | 2000-11-01 |
| CN1308629A (en) | 2001-08-15 |
| CA2331041A1 (en) | 1999-11-11 |
| EP1084118A1 (en) | 2001-03-21 |
| KR20010043216A (en) | 2001-05-25 |
| AU3719699A (en) | 1999-11-23 |
| PL343705A1 (en) | 2001-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301391A3 (en) | Piperazine and piperidine derivatives pharmaceutical compositions containing them and their use | |
| HUP0003362A3 (en) | Piperidine derivatives and pharmaceutical compositions containing them | |
| IL116517A0 (en) | Piperazine derivatives their preparation and pharmaceutical compositions containing them | |
| HUP0101810A3 (en) | Substituted oxoazaheterocyclyl factor xa inhibitors and pharmaceutical compositions containing them | |
| HUP0200130A2 (en) | Substituted pyrazoles as p38 kinase inhibitors and pharmaceutical compositions containing them | |
| IL104690A0 (en) | Piperazine and piperidine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL112249A0 (en) | Heterocyclic pyrimidine derivatives and pharmaceutical compositions containing them | |
| IL110348A0 (en) | Piperazine derivatives and pharmaceutical compositions containing them | |
| IL128942A0 (en) | Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and pharmaceutical compositions containing the same | |
| HUP9701281A2 (en) | Piperidine derivatives as neurokinin antagonists and pharmaceutical compositions containing them | |
| IL116917A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
| HUP0201275A3 (en) | Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts and pharmaceutical composition containing the compound | |
| HUP0203874A3 (en) | Substituted 4-(phenyl-n-alkyl)-piperazine and piperidine derivatives and their use modulators of dopamine neutransmission and pharmaceutical compositions as containing them | |
| IL113814A0 (en) | Diketopiperazine derivatives their preparation pharmaceutical compositions containing them and their use | |
| HUP0002510A3 (en) | Tetrazole derivatives and pharmaceutical compositions containing them | |
| HUP0104922A3 (en) | New piperazine and piperidine derivatives and pharmaceutical compositions containing them and processes for their preparation | |
| HUP9904167A3 (en) | 1,4-disubstituted piperazine and piperidine derivatives, their use and pharmaceutical compositions containing the same | |
| NZ325845A (en) | 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives, preparation and pharmaceutical use thereof | |
| IL122705A0 (en) | 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives their preparation and pharmaceutical compositions containing them | |
| IL112626A0 (en) | Piperazines, their preparation and pharmaceutical or veterinary compositions containing them | |
| HUP9800147A3 (en) | Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them | |
| HUP0000798A3 (en) | New crystal modifications of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and pharmaceutical compositions containing them | |
| IL108601A0 (en) | Piperazine and piperidine derivatives, their preparation and pharmaceutical compositions containing them | |
| IL116930A (en) | 4-(1H-indol-1-YL)-1-piperidinyl derivatives their preparation and pharmaceutical compositions containing them | |
| HUP9801382A3 (en) | Piperazine derivatives as neurokinin antagonists and pharmaceutical compositions containing these compounds |